← All indications
Bipolar Disorder
A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence.
Drugs by status
Approved for this indication (17)
Phase 4 trials (71)
- simvastatin
- melatonin
- allopurinol
- phentermine
- acamprosate
- brexpiprazole
- acetylcysteine
- paroxetine
- chlorpromazine
- ketamine
- citalopram
- clozapine
- cycloserine
- methylphenidate
- duloxetine
- suvorexant
- galantamine
- escitalopram
- sertraline
- naltrexone
- haloperidol
- icosapent ethyl
- iloperidone
- etomidate
- esketamine
- lorazepam
- topiramate
- memantine
- methohexital sodium
- myoinositol
- +41 more
Phase 3 trials (27)
- maltose
- bifeprunoxum
- cannabidiol
- liraglutide
- insulin human
- Epimedium
- iti-007
- maca root
- methylene blue
- tianeptine
- trehalose
- valnoctamide
- verapamil
- xanomeline
- ashwagandha extract
- autologous fecal microbiota
- human fecal microbiota
- albuterol
- fumarate
- levothyroxine
- liothyronine
- dextromethorphan
- tamoxifen
- endoxifen
- lumateperone
- xen1101
- bhv-7000
Phase 2 trials (63)
- nitrous oxide
- mifepristone
- acetylcarnitine
- bezafibrate
- epoetin
- alpha-lipoic acid
- ibuprofen
- progesterone
- digoxin immune fab (ovine)
- perampanel
- ebselen
- eslicarbazepine acetate
- felbamate
- palmitoylethanolamide
- gabapentin
- ethinyl estradiol
- glycine
- scyllo-inositol
- calcium
- aldesleukin
- levetiracetam
- jnj-18038683
- drospirenone
- lu aa39959
- mem 1003
- pentosan polysulfate sodium
- scopolamine
- riluzole
- zuranolone
- ceftriaxone
- +33 more
Phase 1 trials (18)
Other trials (30)
- propofol
- vitamin d3
- apolipoprotein
- bifidobacterium animalis
- Nabiximols
- l-carnosine
- dulaglutide
- fiber
- linseed oil
- folic acid
- sodium oxybate
- ketone
- cabergoline
- bromocriptine
- prazosin
- nicotine
- sertindole
- glucose
- zotepine
- autologous microbiome
- bifidobacterium bifidum
- medium chain triglyceride
- enterococcus faecium
- tea
- armodafinil
- Lactobacillus acidophilus
- lactobacillus casei
- ketone monoester
- lactobacillus rhamnosus
- s-adenosyl methionine
Organizations
Organization Involved with Phase 4 Indications (133)
- Abbott
- Validus Pharmaceuticals
- Takeda
- Cephalon
- McNeil
- Shire
- Bristol-Myers Squibb
- AstraZeneca
- Merck
- Elan Pharmaceuticals
- Sanofi
- Sanofi-Aventis
- Novartis
- Angelini
- GlaxoSmithKline
- Laboratoires Leurquin Mediolanum
- Veterans Medical Research Foundation
- National Institutes of Health (NIH)
- National Institute of Mental Health (NIMH)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- National Institute on Drug Abuse (NIDA)
- University Hospitals Cleveland Medical Center
- Lawson, William B., M.D., PhD, DFAPA
- Guangzhou Psychiatric Hospital
- University of Pennsylvania
- University of Pittsburgh
- Case Western Reserve University
- Cedars-Sinai Medical Center
- Cancer Research Network
- Changhua Christian Hospital
- +103 more
Organization Involved with Phase 3 Indications (56)
- Astellas
- Wyeth
- Allergan
- Cognitive Research Corporation
- Hamilton Health Sciences Corporation
- JDS Pharmaceuticals
- NeuroRx, Inc.
- Solvay
- Sunovion
- TTY Biopharm
- Juvenile Bipolar Research Foundation
- National Institute of Mental Health and Neuro Sciences, India
- Aarhus University
- Centro de Investigación Biomédica en Red (CIBER)
- Dow University of Health Sciences
- McMaster University
- Mood Disorders Center of Ottawa
- Ohio State University
- Palo Alto Veterans Institute for Research
- Universidad Complutense de Madrid
- University of Oklahoma
- University of Ottawa
- University of Valencia
- University of Leipzig
- Dalhousie University
- University of British Columbia
- Laureate Institute for Brain Research
- Hebrew University
- Target Health Inc.
- Government of Pakistan
- +26 more
Organization Involved with Phase 2 Indications (38)
- Novo Nordisk
- Memory Pharmaceuticals
- Pronova BioPharma
- Sage Therapeutics
- Iltoo Pharma
- Repligen Corporation
- National Center for Complementary and Integrative Health (NCCIH)
- Dr. D McIntosh & Dr. K Kjernisted Clinical Research Inc.
- Region Skane
- Region Syddanmark
- American Heart Association
- Lund University
- Mental Health Services in the Capital Region, Denmark
- Monash University
- Sheppard Pratt Health System
- University of Louisville
- Yale University
- University of California, Irvine
- University of Utah
- University of Minnesota
- Sound Pharmaceuticals
- Mental Health Service, Esbjerg
- University of Oxford
- Technion University
- University of Texas at Houston
- Max Planck Institute
- Ewha Womans University
- University of New South Wales
- National Health and Medical Research Council, Australia
- Western Economic Diversification Canada
- +8 more
Organization Involved with Phase 1 Indications (15)
- PPD
- Sandoz
- Sun Pharmaceuticals
- bioRASI, LLC
- Oregon Health and Science University
- Collaborative Neuroscience Network
- Trinity College Dublin
- Compass Research
- Pharmaceutical Research Associates, Inc. (PRA)
- Atlanta Center for Medical Research
- Advanced Pharma CR, LLC
- Evolution Research Group
- New Hope Clinical Research
- Pharma Medica
- University of Texas, Austin
Organization Involved with Other Experimental Indications (41)
- Roxane Laboratories
- The Dana Foundation
- Central South University
- BC Women's Hospital & Health Centre
- Brown University
- University of London
- University of Washington
- RWTH Aachen University
- Sichuan University
- University of Maryland
- University of Regensburg
- University of Rochester
- University of Salerno
- University of Versailles
- University of Zurich
- Stony Brook University
- University of Vienna
- University of Freiburg
- University of Toulouse
- University of Montpellier
- Centre Hospitalier Princesse Grace
- Novum Pharmaceutical Research Services
- University of Lyon
- Hennepin Healthcare
- University of Reims
- Ludwig Maximilians University
- Chhatrapati Sahuji Maharaj Medical University
- Arkansas Research
- University of Paris
- Technical University of Dresden
- +11 more